Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Share-based Compensation (2024 - 2025)

Beta Bionics' Share-based Compensation history spans 2 years, with the latest figure at $4.3 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 177.26% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $16.4 million, up 156.64%, while the annual FY2025 figure was $16.4 million, 156.64% up from the prior year.
  • Share-based Compensation for Q4 2025 was $4.3 million at Beta Bionics, down from $4.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $4.8 million in Q2 2025 and bottomed at $1.4 million in Q1 2024.